<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35912863</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e161167</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI161167</ELocationID><Abstract><AbstractText>SARS-CoV-2-infected individuals may suffer a multi-organ system disorder known as "long COVID" or post-acute sequelae of SARS-CoV-2 infection (PASC). There are no standard treatments, the pathophysiology is unknown, and incidence varies by clinical phenotype. Acute COVID-19 correlates with biomarkers of systemic inflammation, hypercoagulability, and comorbidities that are less prominent in PASC. Macrovessel thrombosis, a hallmark of acute COVID-19, is less frequent in PASC. Female sex at birth is associated with reduced risk for acute COVID-19 progression, but with increased risk of PASC. Persistent microvascular endotheliopathy associated with cryptic SARS-CoV-2 tissue reservoirs has been implicated in PASC pathology. Autoantibodies, localized inflammation, and reactivation of latent pathogens may also be involved, potentially leading to microvascular thrombosis, as documented in multiple PASC tissues. Diagnostic assays illuminating possible therapeutic targets are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahamed</LastName><ForeName>Jasimuddin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurence</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL148123</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> JL has received grants and honoraria from Jazz Pharmaceuticals, Omeros, and Alexion.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35912863</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pii">161167</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality. 2020-21. Lancet. 2022;399(10334):1513&#x2013;1536. doi: 10.1016/S0140-6736(21)02796-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, et al. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z, et al. Long COVID and Health inequities: the role of primary care. Milbank Q. 2021;99(2):519&#x2013;541. doi: 10.1111/1468-0009.12505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12505</ArticleId><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, et al. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015&#x2013;2016. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen AIV, et al. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population [preprint]. Posted on medRxiv February 28, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.27.22271328</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, et al. Clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalization in the UK: a prospective observational study. Lancet Respir Med. doi: 10.1016/s2213-2600(22)00127-8. [published online April 22, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster&#x2014;long-haul Covid. N Engl J Med. 2021;385(7):577&#x2013;579. doi: 10.1056/NEJMp2109285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9(4):ofac060. doi: 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, et al. Post-COVID conditions among adult COVID-19 survivors aged 18-64 and &gt;65 years&#x2014;United States, March 2020-November 2021. MMWR. 2022;71(21):713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation> World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021.  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Updated October 6, 2021. Accessed June 14, 2022.</Citation></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller MC, et al. A longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann Intern Med. doi: 10.7326/m21-4905. [published online May 24, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Iffah R, Gavins FNE. Thromboinflammation in coronavirus disease 2019: the clot thickens. Br J Pharmacol. 2022;179(10):2100&#x2013;2107. doi: 10.1111/bph.15594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15594</ArticleId><ArticleId IdType="pmc">PMC8444860</ArticleId><ArticleId IdType="pubmed">34128218</ArticleId></ArticleIdList></Reference><Reference><Citation>Skendros P, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130(11):6151&#x2013;6157. doi: 10.1172/JCI141374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI141374</ArticleId><ArticleId IdType="pmc">PMC7598040</ArticleId><ArticleId IdType="pubmed">32759504</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurence J, et al. Premortem skin biopsy assessing microthrombi, interferon I antiviral and regulatory proteins, and complement deposition correlates with coronavirus disease 2019 clinical stage. Am J Pathol. doi: 10.1016/j.ajpath.2022.05.006. [published online May 28, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2022.05.006</ArticleId><ArticleId IdType="pmc">PMC9144849</ArticleId><ArticleId IdType="pubmed">35640675</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JE, et al. Coronavirus Disease 2019 (COVID-19) coronary vascular thrombosis: correlation with neutrophil but not endothelial activation. Am J Pathol. 2022;192(1):112&#x2013;120. doi: 10.1016/j.ajpath.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC8479934</ArticleId><ArticleId IdType="pubmed">34599881</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryce C, et al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol. 2021;34(8):1456&#x2013;1467. doi: 10.1038/s41379-021-00793-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00793-y</ArticleId><ArticleId IdType="pmc">PMC8015313</ArticleId><ArticleId IdType="pubmed">33795830</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Pan JY. Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death. Biol Proced Online. 2021;23(1):4. doi: 10.1186/s12575-021-00142-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-021-00142-y</ArticleId><ArticleId IdType="pmc">PMC7816139</ArticleId><ArticleId IdType="pubmed">33472576</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos AC, Bonaca MP. Studying the coagulopathy of COVID-19. Lancet. 2022;399(10320):118&#x2013;119. doi: 10.1016/S0140-6736(21)01906-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01906-1</ArticleId><ArticleId IdType="pmc">PMC8598181</ArticleId><ArticleId IdType="pubmed">34800425</ArticleId></ArticleIdList></Reference><Reference><Citation>The REMAP-CAP, ACTIV-4a, and ATTACC Investigators. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med. 2021;385(9):777&#x2013;789. doi: 10.1056/NEJMoa2103417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2103417</ArticleId><ArticleId IdType="pmc">PMC8362592</ArticleId><ArticleId IdType="pubmed">34351722</ArticleId></ArticleIdList></Reference><Reference><Citation>The ATTACC, ACTIV-4a, and REMAP-CAP Investigators. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385(9):790&#x2013;802. doi: 10.1056/NEJMoa2105911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105911</ArticleId><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereyra D, et al. Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study. Cardiovasc Res. 2021;117(14):2807&#x2013;2820. doi: 10.1093/cvr/cvab308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab308</ArticleId><ArticleId IdType="pmc">PMC8500043</ArticleId><ArticleId IdType="pubmed">34609480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cron RQ, et al. Calming the cytokine storm in COVID-19. Nat Med. 2021;27(10):1672&#x2013;1675. doi: 10.1038/s41591-021-01512-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01512-5</ArticleId><ArticleId IdType="pubmed">34480126</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R, et al. Vasculopathy in COVID-19. Blood. doi: 10.1182/blood.2021012250. [published online January 5, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, et al. Zonulin antagonist, larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: a case series. Crit Care Explor. 2022;10(2):e0641. doi: 10.1097/CCE.0000000000000641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000641</ArticleId><ArticleId IdType="pmc">PMC8860335</ArticleId><ArticleId IdType="pubmed">35211683</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol. 2012;10(9):655&#x2013;666. doi: 10.1038/nrmicro2848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2848</ArticleId><ArticleId IdType="pubmed">22886237</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurence J, et al. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clin Immunol. 2020;219:108555. doi: 10.1016/j.clim.2020.108555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108555</ArticleId><ArticleId IdType="pmc">PMC7410014</ArticleId><ArticleId IdType="pubmed">32771488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastellos DC, et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clin Immunol. 2020;220:108598. doi: 10.1016/j.clim.2020.108598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108598</ArticleId><ArticleId IdType="pmc">PMC7501834</ArticleId><ArticleId IdType="pubmed">32961333</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis [preprint]. Posted on medRxiv March 3, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.02.22271623</ArticleId><ArticleId IdType="pmc">PMC9333998</ArticleId><ArticleId IdType="pubmed">35908569</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainous III AG, et al. COVID-19 post-acute sequelae among adults: 12 month mortality risk. Front Med (Lausanne) 2021;8:778434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8671141</ArticleId><ArticleId IdType="pubmed">34926521</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021;131(8):e147329. doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(1):2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224(11):1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, et al. Characterization and biomarker analysis of post-COVID-19 complications and neurological manifestations. Cells. 2021;10(2):386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C, et al. Post-COVID-19 patients who develop lung fibrotic-like changes have lower circulating levels of IFN-&#x3b2; but higher levels of IL-1&#x3b1; and TGF-&#x3b2;. Biomedicines. 2021;9(12):1931. doi: 10.3390/biomedicines9121931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121931</ArticleId><ArticleId IdType="pmc">PMC8698335</ArticleId><ArticleId IdType="pubmed">34944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelusso MJ, et al. Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms. Clin Infect Dis. 2022;74(11):2083&#x2013;2084. doi: 10.1093/cid/ciab890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab890</ArticleId><ArticleId IdType="pmc">PMC9187313</ArticleId><ArticleId IdType="pubmed">34617982</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterization Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, et al. Kidney outcomes in Long COVID. J Am Soc Nephrol. 2021;32(11):2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Poteat T, et al. Understanding COVID-19 risks and vulnerabilities among black communities in America: the lethal force of syndemics. Ann Epidemiol. 2020;47:1&#x2013;3. doi: 10.1016/j.annepidem.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7224650</ArticleId><ArticleId IdType="pubmed">32419765</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple AC, et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. 2022;9(2):221&#x2013;226. doi: 10.1002/acn3.51498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, et al. Patients with uncomplicated Coronavirus Disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73(3):e826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73(11):e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow AJ, et al. A multisystem, cardio-renal investigation of post-COVID-19 illness. Nat Med. doi: 10.1038/s41591-022-01837-9. [published online May 23, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors J, Levy J. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033&#x2013;2040. doi: 10.1182/blood.2020006000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626&#x2013;638. doi: 10.1038/nri.2016.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaya da Costa M, et al. Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population. Front Immunol. 2018;9:2664. doi: 10.3389/fimmu.2018.02664.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02664</ArticleId><ArticleId IdType="pmc">PMC6255829</ArticleId><ArticleId IdType="pubmed">30515158</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, et al. How common is long COVID in children and adolescents? Pediatr Infect Dis. 2021;40:e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, et al. The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc. 2022;97(3):454&#x2013;464. doi: 10.1016/j.mayocp.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, et al. Findings from Mayo Clinic&#x2019;s post-COVID clinic: PASC phenotypes vary by sex and degree of IL-6 elevation. Mayo Clin Proc. 2022;97(3):430&#x2013;432. doi: 10.1016/j.mayocp.2022.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2022.01.020</ArticleId><ArticleId IdType="pmc">PMC8886352</ArticleId><ArticleId IdType="pubmed">35246280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, et al. Inflammatory profiles and clinical features of Coronavirus 2019 survivors 3 months after discharge in Wuhan, China. J Infect Dis. 2021;224(9):1473&#x2013;1488. doi: 10.1093/infdis/jiab181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab181</ArticleId><ArticleId IdType="pmc">PMC8083630</ArticleId><ArticleId IdType="pubmed">33822106</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36(6):109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanneman K, et al. Combined cardiac fluorodeoxyglucose-positron emission tomography/magnetic resonance imaging assessment of myocardial injury in patients who recently recovered from COVID-19. JAMA Cardiol. 2022;7(3):298&#x2013;308. doi: 10.1001/jamacardio.2021.5505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.5505</ArticleId><ArticleId IdType="pmc">PMC8756363</ArticleId><ArticleId IdType="pubmed">35019953</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, et al. Persistent exertional intolerance after COVID-19. Insights from invasive cardiopulmonary exercise testing. Chest. 2022;16(1):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann Neurol. 2022;91(6):772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, et al. Quantitative CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology. doi: 10.1148/radiol.212170. [published online March 15, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, et al. Pulmonary function and radiological features four months after COVID-19: first results from the national perspective observational Swiss COVID-19 lung study. Eur Resp J. 2021;57(4):2003690. doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5(9):677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyatos P, et al. Post-COVID-19 patients show an increased endothelial progenitor cell production. Transl Res. 2022;243:14&#x2013;20. doi: 10.1016/j.trsl.2022.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2022.01.004</ArticleId><ArticleId IdType="pmc">PMC8785258</ArticleId><ArticleId IdType="pubmed">35085821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J Mens Health. 2021;39(3):466&#x2013;469. doi: 10.5534/wjmh.210055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. 2022;13(1):1745. doi: 10.1038/s41467-022-29440-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers. &#x201d; Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra A, et al. Transcranial doppler ultrasound evidence of active cerebral embolization in COVID-19. J Stroke Cerebrovasc Dis. 2021;30(3):105542. doi: 10.1016/j.jstrokecerebrovasdis.2020.105542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105542</ArticleId><ArticleId IdType="pmc">PMC7837312</ArticleId><ArticleId IdType="pubmed">33341023</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Modjtahedi BS, et al. Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis. JAMA Ophthamol. 2022;140(5):523&#x2013;527. doi: 10.1001/jamaophthalmol.2022.0632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2022.0632</ArticleId><ArticleId IdType="pmc">PMC9011173</ArticleId><ArticleId IdType="pubmed">35420643</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurologic symptoms. Cell Rep Med. 2021;2(5):100288. doi: 10.1016/j.xcrm.2021.100288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100288</ArticleId><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker AME, et al. Neural dysregulation in post-Covid fatigue [preprint]. Posted on medRxiv April 7, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.18.22271040</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C, et al. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Br J Dermatol. 2021;184(1):141&#x2013;150. doi: 10.1111/bjd.19415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19415</ArticleId><ArticleId IdType="pmc">PMC7405151</ArticleId><ArticleId IdType="pubmed">32779733</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314. doi: 10.1016/S1473-3099(20)30986-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirenberg MS, et al. Histopathology of long COVID toe: a case report. J Cutan Pathol. doi: 10.1111/cup.14240. [published online April 2, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.14240</ArticleId><ArticleId IdType="pmc">PMC9111773</ArticleId><ArticleId IdType="pubmed">35366017</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren-Gash C, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10):601&#x2013;610. doi: 10.1016/S1473-3099(09)70233-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(09)70233-6</ArticleId><ArticleId IdType="pubmed">19778762</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeeth L, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611&#x2013;2618. doi: 10.1056/NEJMoa041747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041747</ArticleId><ArticleId IdType="pubmed">15602021</ArticleId></ArticleIdList></Reference><Reference><Citation>Modin D, et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142(21):2080&#x2013;2082. doi: 10.1161/CIRCULATIONAHA.120.050809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050809</ArticleId><ArticleId IdType="pmc">PMC7682795</ArticleId><ArticleId IdType="pubmed">33054349</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599&#x2013;607. doi: 10.1016/S0140-6736(21)00896-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;376:e069590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation> Edding S, et al. Renal function dynamics among mechanically ventilated patients with acute kidney injury (AKI) and COVID-19 pneumonia. Presented at National Kidney Foundation 2022 Conference; April 6&#x2013;10, 2022; Boston, Massachusetts, USA.  https://cme.kidney.org/spa/courses/resource/2022-spring-clinical-meetings/event/home/posters/abstracts?abstractId=8 Accessed June 14, 2022.</Citation></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, et al. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab. 2021;33(8):1577&#x2013;1591. doi: 10.1016/j.cmet.2021.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.015</ArticleId><ArticleId IdType="pmc">PMC8133495</ArticleId><ArticleId IdType="pubmed">34081913</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, et al. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;66(6):949&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Subrahmanian S, et al. Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients. J Thromb Haemost. 2021;19(9):2268&#x2013;2274. doi: 10.1111/jth.15451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15451</ArticleId><ArticleId IdType="pmc">PMC8565501</ArticleId><ArticleId IdType="pubmed">34236752</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: 10-month study. J Neurol. doi: 10.1007/s00415-022-11047-5. [published online March 6, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho CY, et al. Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol. 2022;79(6):544&#x2013;553. doi: 10.1001/jamaneurol.2022.0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0154</ArticleId><ArticleId IdType="pmc">PMC9002725</ArticleId><ArticleId IdType="pubmed">35404378</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184(24):5932&#x2013;5949. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat Methods. 2021;18(5):449&#x2013;453. doi: 10.1038/s41592-021-01145-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01145-z</ArticleId><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S, et al. SARS-CoV-2 infection and persistence throughout the human body and brain [preprint]. Posted on Research Square December 20, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1139035/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XH, et al. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021;31(8):836&#x2013;846. doi: 10.1038/s41422-021-00523-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00523-8</ArticleId><ArticleId IdType="pmc">PMC8208380</ArticleId><ArticleId IdType="pubmed">34135479</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(4):905&#x2013;913.e7. doi: 10.1016/j.cell.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicosia RF, et al. COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury. Am J Pathol. 2021;191(8):1374&#x2013;1384. doi: 10.1016/j.ajpath.2021.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8141344</ArticleId><ArticleId IdType="pubmed">34033751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey AL, et al. SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl Sci. 2021;6(4):331&#x2013;345. doi: 10.1016/j.jacbts.2021.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7909907</ArticleId><ArticleId IdType="pubmed">33681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascarina SM, Ross ED. A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates. FASEB J. 2020;34(8):9832&#x2013;9842. doi: 10.1096/fj.202001351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001351</ArticleId><ArticleId IdType="pmc">PMC7323129</ArticleId><ArticleId IdType="pubmed">32562316</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, et al. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 2020;136(18):2080&#x2013;2089. doi: 10.1182/blood.2020008248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008248</ArticleId><ArticleId IdType="pmc">PMC7596849</ArticleId><ArticleId IdType="pubmed">32877502</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuovo GJ, et al. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann Diag Pathol. 2021;51:151682. doi: 10.1016/j.anndiagpath.2020.151682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151682</ArticleId><ArticleId IdType="pmc">PMC7758180</ArticleId><ArticleId IdType="pubmed">33360731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu JK, et al. SARS-CoV-2 spike protein induces neuroinflammatory blood clots neutralized by fibrin immunotherapy [preprint]. Posted on bioRxiv October 13, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.12.464152</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira C, et al. Fc&#x3b3;R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. doi: 10.1038/s41586-022-04702-4. [published online April 6, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04702-4</ArticleId><ArticleId IdType="pmc">PMC10071495</ArticleId><ArticleId IdType="pubmed">35385861</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank MG, et al. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun. 2022;100:267&#x2013;277. doi: 10.1016/j.bbi.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.007</ArticleId><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, et al. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology. J Virol. 2015;89(5):2710&#x2013;2717. doi: 10.1128/JVI.03346-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03346-14</ArticleId><ArticleId IdType="pmc">PMC4325728</ArticleId><ArticleId IdType="pubmed">25520515</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, et al. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10(6):763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina A, et al. Innate immune modulation induced by EBV lytic infection promotes endothelial cell inflammation and vascular injury in scleroderma. Front Immunol. 2021;12:651013. doi: 10.3389/fimmu.2021.651013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.651013</ArticleId><ArticleId IdType="pmc">PMC8089375</ArticleId><ArticleId IdType="pubmed">33953718</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston R. What might surviving coronavirus disease 2019 look like for people living with HIV? AIDS Patient Care STDS. 2021;35(1):1&#x2013;4. doi: 10.1089/apc.2020.29006.com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/apc.2020.29006.com</ArticleId><ArticleId IdType="pubmed">33347338</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-CoV-2 infection [preprint]. Posted on medRxiv February 26, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.10.22270471</ArticleId><ArticleId IdType="pmc">PMC9444925</ArticleId><ArticleId IdType="pubmed">35866847</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagarn A, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22(2):183&#x2013;195. doi: 10.1016/S1473-3099(21)00648-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00648-4</ArticleId><ArticleId IdType="pmc">PMC8554486</ArticleId><ArticleId IdType="pubmed">34756186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021 [preprint]. Posted on medRxiv January 17, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Changes in the trajectory of long COVID symptoms following COVID-19 vaccination: community-based cohort study. BMJ. 2021;377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, et al. The protective effect of covid-19 vaccination on post-acute sequelae of covid-19 (pasc): a multicenter study from a large national health research network. Open Forum Infect Dis. doi: 10.1093/ofid/ofac228. [published online May 7, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, et al. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. doi: 10.1038/s41591-022-01840-0. [published online May 25, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, et al. Endothelial cell&#x2013;activating antibodies in COVID-19. Arthritis Rheum. doi: 10.1002/art.42094. [published online February 17, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42094</ArticleId><ArticleId IdType="pmc">PMC9082472</ArticleId><ArticleId IdType="pubmed">35174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nature Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro CM, et al. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome. Am J Dermatopathol. 2015;37(5):349&#x2013;356. doi: 10.1097/DAD.0000000000000234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DAD.0000000000000234</ArticleId><ArticleId IdType="pmc">PMC4405909</ArticleId><ArticleId IdType="pubmed">25893747</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhomoud M, et al. Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults. Leuk Lymphoma. 2022;63(2):473&#x2013;477. doi: 10.1080/10428194.2021.1992625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10428194.2021.1992625</ArticleId><ArticleId IdType="pubmed">34668824</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhadad S, et al. C5b-9 and MASP2 deposition in cutaneous and bone marrow microvasculature of patients with allogeneic hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant. doi: 10.1038/s41409-022-01723-5. [published online June 4, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41409-022-01723-5</ArticleId><ArticleId IdType="pubmed">35661836</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen L-A, et al. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389&#x2013;391. doi: 10.1038/s41577-020-0343-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Frame D, et al. Defibrotide therapy for SARS-CoV-2 ARDS. Chest. doi: 10.1016/j.chest.2022.03.046. [published online April 9, 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.03.046</ArticleId><ArticleId IdType="pmc">PMC8993696</ArticleId><ArticleId IdType="pubmed">35413279</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, et al. Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2. Stem Cell Rep. 2021;16(10):2274&#x2013;2288. doi: 10.1016/j.stemcr.2021.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.07.012</ArticleId><ArticleId IdType="pmc">PMC8289700</ArticleId><ArticleId IdType="pubmed">34403650</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri M, et al. Circuit thrombosis reversed and markers of a hypercoagulable state decreased by direct thrombin inhibition in COVID-19. Thrombosis Update. 2020;1:100009. doi: 10.1016/j.tru.2020.100009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tru.2020.100009</ArticleId><ArticleId IdType="pmc">PMC7476895</ArticleId><ArticleId IdType="pubmed">38620488</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz DC, et al. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature. 2022;604(7904):134&#x2013;140. doi: 10.1038/s41586-022-04482-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04482-x</ArticleId><ArticleId IdType="pmc">PMC10377386</ArticleId><ArticleId IdType="pubmed">35130559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluxamine and Paxlovid) for COVID-19: a meta-analysis. Ann Med. 2022;54(1):516&#x2013;523. doi: 10.1080/07853890.2022.2034936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2034936</ArticleId><ArticleId IdType="pmc">PMC8820829</ArticleId><ArticleId IdType="pubmed">35118917</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Ann Intensive Care. 2020;10(1):99. doi: 10.1186/s13613-020-00706-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00706-3</ArticleId><ArticleId IdType="pmc">PMC7393341</ArticleId><ArticleId IdType="pubmed">32737627</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly A, et al. Outcomes of SARS-CoV-2 reinfection [preprint]. Posted on Research Square June 17, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1749502/v1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>